NEW YORK (Reuters Health) – For patients presenting to the emergency department (ED) with migraine, IV prochlorperazine with diphenhydramine is more effective than subcutaneous sumatriptan, a small prospective…
NEW YORK (Reuters Health) – Just like cocaine and other drugs that increase brain dopamine levels, the dopamine agonists used to treat Parkinson disease can also produce a…
NEW YORK (Reuters Health) – New research indicates that operative times are independently and directly linked to the risk of infectious complications and the length of hospital stay.…
NEW YORK (Reuters Health) – Patients treated with high-dose recombinant activated factor VII (rFVIIa) for spontaneous intracerebral hemorrhage face a “small increased risk of what are usually minor…
NEW YORK (Reuters Health) – While the risk of stroke after a transient ischemic attack (TIA) is highest in the first few days, stroke risk remains elevated even…
NEW YORK (Reuters Health) – Extremely few stroke patients have unsuspected coagulopathies that would prevent thrombolysis — a finding that supports the practice of starting the treatment without…
NEW YORK (Reuters Health) – Prophylactic, catheter-based normothermia reduces fever burden in neurointensive care unit patients with severe cerebrovascular disease, according to a report in the December Stroke.…
NEW YORK (Reuters Health) – Stent-assisted coiling of intracranial aneurysms significantly reduces angiographic recurrence, new research shows. But using stents also increases the risk of permanent neurologic complications…
NEW YORK (Reuters Health) – Full assessment of carotid artery plaques requires more than one imaging modality, say researchers from the Netherlands. “Positron emission tomography (PET) imaging allows…
NEW YORK (Reuters Health) – High-flow inhaled oxygen is an effective treatment for cluster headache attacks, investigators said in the Journal of the American Medical Association for December…